A formulation comparison, using a solution and different nanosuspensions of a poorly soluble compound
Year: 2007
Type: article
Institution: AstraZeneca (Sweden)
Language: English
Subfield: Pharmaceutical Science
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2016103258
